http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20130121902-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2de3beee83d9c19278da409b72c777a8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-235
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-235
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-36
filingDate 2011-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39e477cb6a03368cc04c7f2c475e334f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_260e6b6f57968ecc46f78655f0fd693c
publicationDate 2013-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20130121902-A
titleOfInvention New compounds and their pharmaceutical uses
abstract Providing a levodopa prodrug body which overcomes the problems caused by levodopa's blood dynamics, such as the frequency of administration and the occurrence of side effects caused by frequent administration. (2S) -2-amino-3- (3,4-bis ((2- (benzoyloxy) -2-methylpropanoyl) oxy) phenyl) propanoic acid, its salt or solvate thereof is a prodrug of levodopa Since it is a sieve, and gives oral administration of flat levodopa in blood, it is useful as a prophylactic and / or therapeutic drug for Parkinson's disease and / or Parkinson's syndrome which overcomes the problems of the levodopa preparation.
priorityDate 2010-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID427900869
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421025137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89801752
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID427900898
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465911401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466202689
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67952165
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466281130
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13953342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423580174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67952183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467300581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89801702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57344675
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467180038
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468049740
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421940262
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421940269
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164081778

Total number of triples: 47.